CellCept, Mycophenolate

CellCept, Mycophenolate Newswire

Comprehensive Real-Time News Feed for CellCept, Mycophenolate (generic).

Results 1 - 20 of 50 in CellCept, Mycophenolate (generic)

  1. Successful treatment of refractory childhood pemphgus vulgaris with...Read the original story

    Saturday Feb 21 | CiteULike

    Pediatric dermatology , Vol. 22, No. 5. , pp. 461-464, doi:10.1111/j.1525-1470.2005.00118.x To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

    Comment?

  2. Aurinia To Initiate An Open Label Clinical Study To Investigate The...Read the original story

    Sunday Feb 8 | BioSpace

    Aurinia Pharmaceuticals Inc. today announced that it will initiate an open label, exploratory study to assess the short term predictors of response using voclosporin in combination with mycophenolate mofetil in patients with active lupus nephritis. AURION will examine biomarkers of disease activity at 8 weeks and their ability to predict response at 24 and 48 weeks.

    Comment?

  3. Pharmacogenomics: Personalizing Pediatric Heart Transplantation...Read the original story

    Monday Feb 2 | Circulation

    Correspondence to Steven A. Webber, James C. Overall Professor of Pediatrics, Chair, Department of Pediatrics, Vanderbilt University School of Medicine, Pediatrician-in-Chief, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN 37232. E-mail In recent years, outcomes for pediatric cardiac transplantation have steadily improved, with current 5-year overall survival rates estimated at 83%.

    Comment?

  4. Journal ClubRead the original story

    Friday Jan 30 | Kidney International

    In kidney transplant recipients, persistent hypercalcemia and hypophosphatemia associated with hyperparathyroidism may complicate post-transplantation care by increasing the risk of fracture, vascular calcification, and renal allograft nephropathy. Satisfactory long-term management with loop diuretics and antiresorptive agents to correct hypercalcemia or phosphate supplements to correct hypophosphatemia is difficult to obtain and may be harmful.

    Comment?

  5. Pregnancy in renal transplant recipients.Read the original story

    Tuesday Jan 27 | CiteULike

    Fertility in women with kidney failure is restored by transplantation. It requires careful planning and is only advisable in women with good kidney function, controlled blood pressure, and general good health.

    Comment?

  6. A neurologist's guide to safe use of immunomodulatory therapies.Read the original story

    Jan 12, 2015 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Increased understanding of the pathogenesis of immune-mediated neurologic conditions with concomitant development of new therapeutic agents modulating various aspects of the immune system has resulted in the use of innovative therapies in the treatment of these diseases.

    Comment?

  7. Insights into the role of genetic variants in kidney diseaseRead the original story w/Photo

    Jan 12, 2015 | Medical News Today

    New research provides insights into the ties between certain genetic variants and kidney disease in African Americans. The genetic association is one of the strongest ever reported for a common disease, and these latest findings may help improve diagnosis and treatment.

    Comment?

  8. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.Read the original story

    Jan 10, 2015 | CiteULike

    Idiopathic membranous nephropathy is the most common form of nephrotic syndrome in adults. The disease shows a benign or indolent course in the majority of patients, with a rate of spontaneous complete or partial remission of nephrotic syndrome as high as 30% or more.

    Comment?

  9. Study provides insights into the role of genetic variants in kidney diseaseRead the original story w/Photo

    Jan 8, 2015 | PhysOrg Weblog

    New research provides insights into the ties between certain genetic variants and kidney disease in African Americans. The genetic association is one of the strongest ever reported for a common disease, and these latest findings may help improve diagnosis and treatment.

    Comment?

  10. Rituximab for the treatment of IgG4-related orbital disease: experience from five casesRead the original story w/Photo

    Jan 7, 2015 | Eye

    Correspondence: A Wu, South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Level 8, East Wing, Adelaide, SA 5000, Australia. Tel: +61 8 8222 2729; Fax: +61 8 8222 2741.

    Comment?

  11. Haploidentical hematopoietic SCT may be superior to conventional...Read the original story

    Jan 7, 2015 | Bone Marrow Transplantation

    Correspondence: Professor X-J Huang, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Peking-Tsinghua Center for Life Sciences, 11 Xizhimen South Street, Beijing 100044, China. E-mail: huangxiaojun@bjmu.edu.cn of high-risk adult ALL patients in their first complete remission are able to receive an HLA-matched sibling stem cell transplant.

    Comment?

  12. DLI after haploidentical BMT with post-transplant CYRead the original story

    Jan 7, 2015 | Bone Marrow Transplantation

    Correspondence: Dr A Bacigalupo, Divisione Ematologia e Trapianto di Midollo Osseo, IRCCS San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy. E-mail: andrea.bacigalupo@hsanmartino.it Forty-two patients relapsing after an unmanipulated haploidentical BM transplant and post-transplant CY , were given 108 DLI, with median interval from transplant of 266 days .

    Comment?

  13. Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus...Read the original story

    Jan 7, 2015 | Bone Marrow Transplantation

    E-mail: ratanath@karmanos.org We performed a retrospective analysis of the outcome of 197 consecutive unrelated donor transplant recipients who received GVHD prophylaxis either TM regimen or TM , P <0.001) and more favorable global chronic GVHD severity . Univariate analyses showed improved OS and PFS of patients who received TM kg given in conjunction with TM improved GVHD prophylaxis without increased risk of relapse.

    Comment?

  14. KIR and HLA genotypes have no identifiable role in single-unit...Read the original story

    Jan 7, 2015 | Bone Marrow Transplantation

    Umbilical cord blood is widely used as an alternative hematopoietic stem cell source. The use of double-unit CB grafts is a common strategy to augment graft cell dose and successfully leads to engraftment by a single unit.

    Comment?

  15. Multitarget Therapy for Induction Treatment of Lupus NephritisRead the original story

    Jan 5, 2015 | Annals of Internal Medicine

    The full report is titled "Multitarget Therapy for Induction Treatment of Lupus Nephritis. A Randomized Trial."

    Comment?

  16. Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanerceptRead the original story

    Dec 10, 2014 | BioMed Central

    BackgroundSeveral disorders may present with mononeuritis multiplex and the etiological diagnosis can be challenging.Case presentationWe report a 42-year old female who presented with severe lower limb neuropathic pain, asymmetric weakness and sensory impairment and was diagnosed with mononeuritis multiplex. Biopsy showed a granulomatous vasculitic process with eosinophils, scarce granulomata and axonal neuropathy and granulomatosis with poliangiitis was assumed.

    Comment?

  17. Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized, Controlled Trial.Read the original story

    Dec 5, 2014 | CiteULike

    Treatment of lupus nephritis remains challenging. To assess the efficacy and safety of a multitarget therapy consisting of tacrolimus, mycophenolate mofetil, and steroid compared with intravenous cyclophosphamide and steroid as induction therapy for LN.

    Comment?

  18. Treatment of lupus nephritis: practical issues in Asian countries.Read the original story

    Dec 5, 2014 | CiteULike

    Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus in Asian patients, and is an important cause of renal failure in Asian countries. Immunosuppressive treatments of LN have evolved over the past few decades and resulted in improvements in patient outcomes.

    Comment?

  19. Maintenance therapy of lupus nephritis with mycophenolate or...Read the original story

    Dec 5, 2014 | CiteULike

    The objective of this study was to summarize the comparative efficacy and safety of MMF and AZA as maintenance therapy for LN. Systematic review and meta-analysis of randomized clinical trials of MMF and AZA as maintenance therapy for LN were performed based on a sensitive search.

    Comment?

  20. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic reviewRead the original story

    Dec 4, 2014 | BioMed Central

    IgA nephropathy is the most common primary glomerular disease worldwide and also the most frequent cause of kidney failure. Mycophenolate mofetil is a selective immunosuppressant widely used in many autoimmune diseases.

    Comment?